Rulings (35)
  • ESTHETURK Danismanlik A.S. t/a You Clinic

    • Search (paid), Social media (paid ad)
    • 23 September 2026

    A paid-for Meta ad and a paid-for Google ad for a medical clinic made misleading claims that stem cell treatment could treat or alleviate the traits associated with autism or stop the progression of autism. 

  • Here We Flo Ltd t/a Flo

    • Social media (own site)
    • 23 September 2026

    Three Instagram posts for a period product company made misleading environmental claims, including by failing to make the basis of environmental claims clear. 

  • International Medical Center LLC t/a Swiss Medica

    • Upheld
    • Social media (paid ad)
    • 23 September 2026

    A paid-for Meta ad for a medical clinic made misleading claims that stem cell treatment could treat or alleviate the traits associated with autism. 

  • Linden Clinics t/a Linden Stem Cell

    • Upheld
    • Social media (paid ad)
    • 23 September 2026

    A paid-for Facebook ad for a stem cell therapy clinic made misleading claims that stem cell therapy was effective in improving the traits associated with autism in children. 

  • Reliable Medicare Ltd

    • Upheld
    • Website (own site)
    • 23 September 2026

    Three product listings on the website of a medical aesthetics and skincare supplier made misleading savings claims. 

  • Rumi Pulse t/a Rumi Pulse Medical Tourism Agency

    • Upheld
    • Social media (paid ad)
    • 23 September 2026

    A paid-for Meta ad for a medical clinic made misleading claims that stem cell treatment could treat or alleviate the traits associated with autism. 

  • SheMed Ltd

    • Upheld
    • Social media (paid ad)
    • 02 September 2026

    A paid-for Reddit ad for a female-focused medical weight-loss service promoted weight-loss prescription-only medicines to the public, against the law and our rules, was likely to exploit consumers’ insecurities relating to body image and weight and was irresponsible.

  • BioIdentical Hormone Therapy Ltd t/a BioID Health

    • Upheld
    • Social media (paid ad)
    • 26 August 2026

    Two paid-for Facebook ads for a hormone health consultant made misleading claims that they could provide more effective tests and services for low testosterone than GPs and were irresponsible by implying that GPs were insufficiently thorough.

  • Fenix Biomed BV

    • Upheld
    • Website (own site)
    • 19 August 2026

    A website for a human tissue donation service misleadingly implied they were based in the UK.

  • Gary Baron

    • Upheld
    • Website (own site)
    • 12 August 2026

    A webpage for Gary Baron Counselling claimed that he was a member of the British Association for Counselling and Psychotherapy (BACP) when this wasn’t the case.

  • BetterYou Ltd t/a Better You

    • Upheld
    • Magazine (paid ad)
    • 17 June 2026

    A magazine ad for a supplement company made misleading claims that their product delivered vitamin D “quickly” and enabled fast absorption of vitamin D into the body. 

  • HealthTracker Apps t/a Blood Pressure Monitor App

    • Upheld
    • App (paid ad)
    • 17 June 2026

    Two paid-for in-app ads for a health app made medical claims for a product that wasn’t registered as a medical device and misleadingly implied that their app could monitor blood pressure and heart rate.

  • Hume Health LLC t/a HumeHealth

    • Upheld
    • Social media (paid ad)
    • 17 June 2026

    Three paid-for YouTube ads and a paid-for Facebook ad for Hume Health made medical claims for products that weren’t registered as medical devices, discouraged essential treatment for conditions for which medical supervision should be sought and exaggerated the capabilities of their products.

  • Novabeyond Ltd t/a Blood Pressure-Monitor Tracker App

    • Upheld
    • Search (paid)
    • 17 June 2026

    An in-app ad and a paid-for Google ad for a health app made medical claims for a product that wasn’t registered as a medical device and made misleading claims that their product could monitor blood pressure.

  • P&L Studio t/a Blood Pressure

    • Upheld
    • App (paid ad)
    • 17 June 2026

    A paid-for in-app ad for a health app misleadingly implied that it could monitor blood pressure and heart rate.

  • Menwell Ltd t/a Voy

    • Upheld
    • Email
    • 27 May 2026

    Three emails for an online pharmacy promoted prescription-only medicines to the public against the law and our rules. The ads were also socially irresponsible by creating an undue sense of urgency for people who were considering medicated weight-loss programmes. 

  • GLP-1 Pro Ltd t/a GuLP-1

    • Upheld
    • 06 May 2026

    Two webpages for a food supplement company made claims that a supplement could prevent, treat or cure human disease and made unauthorised health and medicinal claims. The ads also compared the effects of a food supplement to those associated with weight-loss prescr...

  • Medilife Clinic Enfield

    • Upheld
    • Social media (paid ad)
    • 06 May 2026

    A paid-for Instagram ad for a health clinic made claims that their treatments could alleviate or treat the traits of autism without suitable evidence to support these claims. The ad also discouraged essential treatment for conditions for which medical supervision should be sought. 

  • Juniper Technologies UK Ltd t/a Juniper

    • Upheld
    • Social media (paid ad)
    • 08 April 2026

    Two paid-for Instagram ads for an online pharmacy promoted prescription-only medicines to the public, which is against the law and our rules. They also created an undue sense of urgency for members of the public who are considering medicated weight-loss programmes.

  • Juniper Technologies UK Ltd t/a Juniper

    • Upheld
    • Social media (influencer or affiliate ad)
    • 08 April 2026

    Posts in weight-loss support groups on Facebook didn't make clear they were paid for by the advertiser and they promoted prescription-only medicines to the public, which is against the law and our rules.